Cargando…

A Decrease in Glucose Variability Does Not Reduce Cardiovascular Event Rates in Type 2 Diabetic Patients After Acute Myocardial Infarction: A reanalysis of the HEART2D study

OBJECTIVE: To assess the effect of intraday glucose variability (GV) on cardiovascular outcomes in a reanalysis of Hyperglycemia and Its Effect After Acute Myocardial Infarction on Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus (HEART2D) study data. RESEARCH DESIGN AND METHODS: Ty...

Descripción completa

Detalles Bibliográficos
Autores principales:	Siegelaar, Sarah E., Kerr, Lisa, Jacober, Scott J., Devries, J. Hans
Formato:	Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2011
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3064040/ https://www.ncbi.nlm.nih.gov/pubmed/21447661 http://dx.doi.org/10.2337/dc10-1684

Ejemplares similares

Glucose variability does not contribute to the development of peripheral and autonomic neuropathy in type 1 diabetes: data from the DCCT
por: Siegelaar, S. E., et al.
Publicado: (2009)

2-h postchallenge plasma glucose predicts cardiovascular events in patients with myocardial infarction without known diabetes mellitus
por: Henareh, Loghman, et al.
Publicado: (2012)

Reanalysis and Simulation Suggest a Phylogenetic Microarray Does Not Accurately Profile Microbial Communities
por: Midgley, David J., et al.
Publicado: (2012)

Impact of Admission Glycemic Variability, Glucose, and Glycosylated Hemoglobin on Major Adverse Cardiac Events After Acute Myocardial Infarction
por: Su, Gong, et al.
Publicado: (2013)

Accuracy and Reliability of Continuous Glucose Monitoring in the Intensive Care Unit: A Head-to-Head Comparison of Two Subcutaneous Glucose Sensors in Cardiac Surgery Patients
por: Siegelaar, Sarah E., et al.
Publicado: (2011)

Glucose Variability: Where It Is Important and How to Measure It
por: DeVries, J. Hans
Publicado: (2013)

Estimating Subseasonal Variability and Trends in Global Atmosphere Using Reanalysis Data
por: Žagar, N., et al.
Publicado: (2018)

Interventions supporting long term adherence and decreasing cardiovascular events after myocardial infarction (ISLAND): pragmatic randomised controlled trial
por: Ivers, Noah M, et al.
Publicado: (2020)

Does variability in automated perfusion software outputs for acute ischemic stroke matter? Reanalysis of EXTEND perfusion imaging
por: Bivard, Andrew, et al.
Publicado: (2021)

Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis
por: Bolland, Mark J, et al.
Publicado: (2010)

Patients with diabetes in the intensive care unit; not served by treatment, yet protected?
por: Siegelaar, Sarah E, et al.
Publicado: (2010)

Statistical reanalysis of vascular event outcomes in primary and secondary vascular prevention trials
por: Woodhouse, Lisa J., et al.
Publicado: (2021)

Acute myocardial infarction versus other cardiovascular events in community-acquired pneumonia
por: Aliberti, Stefano, et al.
Publicado: (2015)

Visfatin associated with major adverse cardiovascular events in patients with acute myocardial infarction
por: Zheng, Meifan, et al.
Publicado: (2020)

The association between plasma furin and cardiovascular events after acute myocardial infarction
por: Liu, Zhi-Wei, et al.
Publicado: (2021)

Cardiovascular events and death after myocardial infarction or ischemic stroke in an older Medicare population
por: Li, Suying, et al.
Publicado: (2019)

Measuring Heart Rate Variability in Patients Admitted with ST-Elevation Myocardial Infarction for the Prediction of Subsequent Cardiovascular Events: A Systematic Review
por: Brinza, Crischentian, et al.
Publicado: (2021)

Sensitivity of Amazonian TOA flux diurnal cycle composite monthly variability to choice of reanalysis
por: Dodson, J. Brant, et al.
Publicado: (2016)

Glycaemic variability is associated with adverse cardiovascular outcomes in patients hospitalised with an acute myocardial infarction
por: Chai, Thora Y., et al.
Publicado: (2019)

Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women’s Health Initiative limited access dataset and meta-analysis
por: Bolland, Mark J, et al.
Publicado: (2011)

Sodium–Glucose cotransporter 2 inhibitor empagliflozin decreases ventricular arrhythmia susceptibility by alleviating electrophysiological remodeling post-myocardial-infarction in mice
por: Xue, Genlong, et al.
Publicado: (2022)

Effects of Prandial Versus Fasting Glycemia on Cardiovascular Outcomes in Type 2 Diabetes: The HEART2D trial
por: Raz, Itamar, et al.
Publicado: (2009)

Prevalence and association of medication nonadherence with major adverse cardiovascular events in patients with myocardial infarction
por: Hou, Yunfeng, et al.
Publicado: (2019)

Association of Serum BAFF Levels with Cardiovascular Events in ST-Segment Elevation Myocardial Infarction
por: Wang, Ziyang, et al.
Publicado: (2023)

A case report of myocardial infarction with non-obstructive coronary artery disease: Graves’ disease-induced coronary artery vasospasm
por: Klomp, Margo, et al.
Publicado: (2020)

Left ventricular global function index assessed by cardiovascular magnetic resonance for the prediction of cardiovascular events in ST-elevation myocardial infarction
por: Eitel, Ingo, et al.
Publicado: (2015)

Quantitative characterization of myocardial infarction by cardiovascular magnetic resonance predicts future cardiovascular events in patients with ischemic cardiomyopathy
por: Yokota, Hajime, et al.
Publicado: (2008)

Association of Glucose‐Dependent Insulinotropic Polypeptide Levels With Cardiovascular Mortality in Patients With Acute Myocardial Infarction
por: Kahles, Florian, et al.
Publicado: (2021)

Enterovirus cardiovascular infection and acute myocardial infarction
por: Andreoletti, L., et al.
Publicado: (2006)

Investigating the Structure of Intelligence Using Latent Variable and Psychometric Network Modeling: A Commentary and Reanalysis
por: Schmank, Christopher J., et al.
Publicado: (2021)

The association between glucose-related variables and plaque morphology in patients with ST-segment elevated myocardial infarction
por: Liu, Jinxin, et al.
Publicado: (2020)

Association of CHA2DS2-VASC Score with in-Hospital Cardiovascular Adverse Events in Patients with Acute ST-Segment Elevation Myocardial Infarction
por: Fang, Caoyang, et al.
Publicado: (2022)

The impact of platelet function or C-reactive protein, on cardiovascular events after an acute myocardial infarction
por: Modica, Angelo, et al.
Publicado: (2009)

Risk Factors Associated With Major Cardiovascular Events 1 Year After Acute Myocardial Infarction
por: Wang, Yun, et al.
Publicado: (2018)

Cost-Effectiveness of Alirocumab for the Secondary Prevention of Cardiovascular Events after Myocardial Infarction in the Chinese Setting
por: Liang, Zhe, et al.
Publicado: (2021)

Remnant Cholesterol Predicts Risk of Cardiovascular Events in Patients With Myocardial Infarction With Nonobstructive Coronary Arteries
por: Gao, Side, et al.
Publicado: (2022)

Office-Visit Heart Rate and Long-Term Cardiovascular Events in Patients with Acute Myocardial Infarction
por: Byeon, Jaeho, et al.
Publicado: (2023)

Association of triglyceride levels with adverse cardiovascular events in patients with ST-segment elevation myocardial infarction
por: Yildiz, Mehmet, et al.
Publicado: (2023)

Glucose Variability: How Does It Work?
por: Klimontov, Vadim V., et al.
Publicado: (2021)

Post Hoc Subgroup Analysis of the HEART2D Trial Demonstrates Lower Cardiovascular Risk in Older Patients Targeting Postprandial Versus Fasting/Premeal Glycemia
por: Raz, Itamar, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_7tp8tgshhh1adjoq2or2l8fie9